In the News
RadPharm to present at the upcoming ASCO 2009 Annual Meeting
RadPharm Inc., is pleased to announce the publication of an abstract and the release of two abstracts to be presented during oral presentations at the upcoming American Society of Clinical Oncology (ASCO) Annual Meeting, which is being held in Orlando, FL from May 30-June 1, 2009.
Published Abstract:
Distribution of Metastases in NSCLC: Economic Impact of Imaging
Authors: Cassandra Pineda, BS (Biology); Kathy-Ann Cadogan, MBBS; Michael Cadogan, MD
Background
Purpose: to investigate the usefulness and cost-effectiveness of routine pelvic CT scans in patients with NSCLC.
Given that many patients have metastases to several organs, one important question is – “what is the frequency of metastases in the chest, the abdomen, the pelvis, elsewhere?”
Presentations:
The impact of the inclusion of clinical data review on overall radiographic response and progression in oncology clinical trials as assessed by blinded independent central review.
Authors: N. Wangler, B.S., K. Borradaile, M.S., R. Ford, M.D., RadPharm, Princeton, NJ
Session Type: Poster Discussion
Date: Sunday, May 31, 2009
Time: 8:00 AM - 12:00 PM
Location: Level 3, W315A
Date: Sunday, May 31, 2009
Time: 11:30 AM - 12:30 PM
Location: Level 2, W203C
Room Capacity: TS=395; CR=70; 4,928 sq. ft.
Analysis of the rate of non-target disease progression in patients with stable or responding target disease by the Response Evaluation Criteria in Solid Tumors (RECIST).
Authors: K. Borradaile, M.S., R. Ford, M.D.,
RadPharm, Princeton, NJ
Session Type: General Poster Session
Date: Saturday, May 30, 2009
Time: 2:00 PM - 6:00 PM
Location: Level 2, West Hall C
About RadPharm Inc.
RadPharm, a leading imaging core lab, provides complete image management services to global pharmaceutical, biotechnology and medical device organizations, facilitating successful new drug development. RadPharm employs full-time, board certified, sub-specialty trained radiologists, nuclear physicians and medical oncologists to focus on the Medicine Behind the Image™ and offer global trial sponsors medical expertise, advanced technology and proven operational processes to deliver accurate, timely trial data. RadPharm has supported over 300 clinical trials across more than 60 countries and 5000 unique sites. For more information, please visit www.radpharm.com
|
